Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Non-cash Items: 2015-2024

Historic Non-cash Items for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $6.7 million.

  • Syndax Pharmaceuticals' Non-cash Items fell 87.92% to $6.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.7 million, marking a year-over-year decrease of 87.92%. This contributed to the annual value of $6.7 million for FY2024, which is 21.65% up from last year.
  • As of FY2024, Syndax Pharmaceuticals' Non-cash Items stood at $6.7 million, which was up 21.65% from $5.5 million recorded in FY2023.
  • Syndax Pharmaceuticals' Non-cash Items' 5-year high stood at $68.6 million during FY2021, with a 5-year trough of $4.0 million in FY2020.
  • In the last 3 years, Syndax Pharmaceuticals' Non-cash Items had a median value of $5.5 million in 2023 and averaged $5.5 million.
  • Per our database at Business Quant, Syndax Pharmaceuticals' Non-cash Items spiked by 1,608.21% in 2021 and then tumbled by 93.71% in 2022.
  • Yearly analysis of 5 years shows Syndax Pharmaceuticals' Non-cash Items stood at $4.0 million in 2020, then skyrocketed by 1,608.21% to $68.6 million in 2021, then tumbled by 93.71% to $4.3 million in 2022, then grew by 26.76% to $5.5 million in 2023, then grew by 21.65% to $6.7 million in 2024.